abstract |
The invention relates to methods for treating or preventing anemia caused by a chronic disease, iron deficiency, microcytosis or microcytic anemia, anemia associated with cytokine activity, anemia that is difficult to treat with erythropoietin (EPO), which is exogenously administered using an effective amount of a HIF inhibitor prolyl hydroxylase which is a structural mimetic of 2-oxoglutarate. |